Overview

Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety and effectiveness of ABT-510 in subjects with locally advanced or metastatic soft tissue sarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
Abbott